Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of MDR1 gene (C3435T) polymorphism and gene expression profiling in lung cancer patients treated with platinum-based chemotherapy.

Molecular diagnosis & therapy - 1 Oct 2015

Subhani Syed, Jamil Kaiser, Nirni Sharanabasappa Somanath

Abstract excerpt

INTRODUCTION: Chemotherapy is the standard and recommended treatment for lung cancer apart from surgery and radiotherapy. Chemotherapy is administered as mono-agents or as combination therapy. In this study, we examined the role of MDR1 C3435T polymorphisms in lung cancer patients undergoing chemotherapy. METHODS AND RESULTS: We genotyped 126 cases with lung cancer and 111 healthy controls, using the polymerase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ATP Binding Cassette Transporter, Subfamily B

Share to Cisplatin

Share to Lung Neoplasms

Share to Paclitaxel

Share to Treatment Outcome

Share to Up-Regulation

Source

Identifiers

PMID: 26288241
DOI: 10.1007/s40291-015-0154-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of MDR1 gene (C3435T) polymorphism and gene expression profiling in lung cancer patients treated with platinum-based chemotherapy.PMID 26288241Read ↗

MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer.Semantic proximity Read ↗

Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer.Semantic proximity Read ↗

MDR1 C3435T polymorphism in patients with breast cancer.Semantic proximity Read ↗

MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.Semantic proximity Read ↗

Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma.Semantic proximity Read ↗

MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer.Semantic proximity Read ↗

MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies.Semantic proximity Read ↗

Association between MDR1 C3435T polymorphism and risk of breast cancer.Semantic proximity Read ↗

Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.Semantic proximity Read ↗

Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients.Semantic proximity Read ↗

Association between the MDR1 gene variant C3435T and risk of leukaemia: a meta-analysis.Semantic proximity Read ↗

MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.